Alffenaar [47] | The Netherlands | Open-label, prospective, pharmacokinetic | Monocentre, university medical centre | 2007–2008 |
Anger [34] | USA | Retrospective | Multicentre, public and private clinics | 2000–2006 |
De Lorenzo [35] | Italy | Retrospective | Monocentre, tuberculosis reference centre | 2009–2010 |
Fortún [22] | Spain | Retrospective | Monocentre, Ramon y Cajal Hospital (Madrid, Spain) | 1999–2004 |
Nam [46] | South Korea | Retrospective | Monocentre, university medical centre | 2004–2007 |
Migliori [8] | Belarus, Germany, Italy, Switzerland | Retrospective, controlled, nonrandomised, unblinded | Multicentre, 21 public hospitals and tuberculosis reference centres | 2001–2007 |
Park [45] | South Korea | Retrospective | Monocentre, university medical centre | 2003–2006 |
Schecter [30] | USA | Retrospective | Multicentre, public clinics | 2003–2007 |
Singla [31] | India | Prospective | Monocentre, tertiary centre | 2006–2011 |
Udwadia [32] | India | Prospective, nonrandomised | Monocentre, private tertiary centre | 2000–2007 |
Villar [33] | Portugal | Prospective | Multicentre, public clinics | 2004–2009 |
von der Lippe [44] | Norway | Retrospective | Monocentre, university medical centre | 1998–2002 |